Besides, the clinicopathological features, including tumor grade, histology diagnosis, IDH status, 1p/19q codeletion, TERT promoter status, ATRX status, and MGMT promoter status, were also integrated (Figure 5A). This evidence concerns the gene MGMT and neoplasm.